Literature DB >> 8224064

Pharmacologic characterization of opioid peptide release from chromaffin cell transplants using a brain slice superfusion method.

J D Ortega1, J Sagen.   

Abstract

A simple chamber and an inexpensive superfusion system for studying mammalian brain slices containing neural transplants is described. With this method, rat brain slices containing bovine chromaffin cell transplants can be maintained for several hours, allowing for the determination of neurochemical characteristics and pharmacologic responsiveness of the grafted cells. Using this technique, basal and nicotine-stimulated release of metenkephalin from rat periaqueductal gray slices containing bovine chromaffin cell transplants were measured. Results showed that met-enkephalin release can be increased by nicotinic stimulation in slices containing chromaffin cell, but not control implants, for at least 8 weeks postimplantation. Furthermore, this response was dose-related. These results are in good agreement with previous behavioral studies and provide corroborative evidence for the mechanism of pain reduction by the release of opioid peptides from chromaffin cell transplants in the periaqueductal gray. This study demonstrates that neurochemical and pharmacologic analyses of neural transplants using a superfused brain slice method can be a complementary approach in determining the underlying mechanisms of neural transplants in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224064     DOI: 10.1007/bf00227130

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  40 in total

1.  In vivo microdialysis: a new approach for the study of functional activity of grafted monoaminergic neurons and their interaction with the host brain.

Authors:  P Kalén; M A Cenci; A Daszuta; O Lindvall; A Björklund
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

2.  Intracerebral microdialysis as a tool to monitor transmitter release from grafted cholinergic and monoaminergic neurons.

Authors:  P Kalén; O G Nilsson; M A Cenci; E Rosengren; O Lindvall; A Björklund
Journal:  J Neurosci Methods       Date:  1990-09       Impact factor: 2.390

3.  Pharmacologic consequences of the vascular permeability of chromaffin cell transplants in CNS pain modulatory regions.

Authors:  J Sagen; G D Pappas
Journal:  Exp Neurol       Date:  1988-12       Impact factor: 5.330

4.  Regulation of rat adrenal medullary enkephalins by glucocorticoids.

Authors:  B C Yoburn; S O Franklin; S E Calvano; C E Inturrisi
Journal:  Life Sci       Date:  1987-06-29       Impact factor: 5.037

Review 5.  The use of brain slices in central nervous system pharmacology.

Authors:  T Dunwiddie; A Mueller; A Basile
Journal:  Fed Proc       Date:  1983-09

6.  Adrenal medulla grafts enhance functional activity of the striatal dopamine system following substantia nigra lesions.

Authors:  J B Becker; W J Freed
Journal:  Brain Res       Date:  1988-10-18       Impact factor: 3.252

7.  Increased levels of Met-enkephalin-like immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplants.

Authors:  J Sagen; J E Kemmler
Journal:  Brain Res       Date:  1989-11-13       Impact factor: 3.252

8.  Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells.

Authors:  B G Livett; D M Dean; L G Whelan; S Udenfriend; J Rossier
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

9.  Nonadrenergic modulation by clonidine of the cosecretion of catecholamines and enkephalins in adrenal chromaffin cells.

Authors:  T T Nguyen; A De Léan
Journal:  Can J Physiol Pharmacol       Date:  1987-05       Impact factor: 2.273

10.  Short-term immunosuppression enhances long-term survival of bovine chromaffin cell xenografts in rat CNS.

Authors:  J D Ortega; J Sagen; G D Pappas
Journal:  Cell Transplant       Date:  1992       Impact factor: 4.064

View more
  3 in total

1.  Pharmacologic specificity of antidepressive activity by monoaminergic neural transplants.

Authors:  D D Dougherty; C E Sortwell; J Sagen
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

2.  Chromaffin cell xenografts in the rat neocortex can produce antidepressive activity in the forced swimming test.

Authors:  C E Sortwell; G D Pappas; J Sagen
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

3.  Review of the history and current status of cell-transplant approaches for the management of neuropathic pain.

Authors:  Mary J Eaton; Yerko Berrocal; Stacey Q Wolfe; Eva Widerström-Noga
Journal:  Pain Res Treat       Date:  2012-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.